Treatment Patterns and Adherence among Patients with Chronic Hepatitis C Virus in a US Managed Care Population

Author： Mitra Debanjali   Davis Keith L.   Beam Cynthia   Medjedovic Jasmina   Rustgi Vinod  

Publisher： Blackwell Publishing

ISSN： 1098-3015

Source： Value in Health, Vol.13, Iss.4, 2010-06, pp. : 479-486

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment Interruptions and Non-Adherence with Imatinib and Associated Healthcare Costs: A Retrospective Analysis among Managed Care Patients with Chronic Myelogenous Leukaemia

By Darkow Theodore  

PharmacoEconomics, Vol. 25, Iss. 6, 2007-01 ,pp. : 481-496

Adis International

Access to resources Recommend Favorite

Dosing Patterns and Treatment Costs of Erythropoietic Agents in Elderly Patients with Pre-Dialysis Chronic Kidney Disease in Managed Care Organisations

By Mei Sheng Duh  

Drugs & Aging, Vol. 23, Iss. 12, 2006-01 ,pp. : 969-976

Adis International

Access to resources Recommend Favorite

IL28B genetic variations are associated with treatment response of patients with chronic hepatitis C in a Chinese Han population

By  

Journal of Digestive Diseases, Vol. 16, Iss. 2, 2015-02 ,pp. : 90-97

John Wiley & Sons Inc

Access to resources Recommend Favorite

Treatment Patterns, Outcomes and Costs Among Elderly Patients with Chronic Myeloid Leukaemia: A Population-Based Analysis

By Joseph Menzin  

Drugs & Aging, Vol. 21, Iss. 11, 2004-01 ,pp. : 737-746

Adis International

Access to resources Recommend Favorite

NS5A inhibitor, daclatasvir, for the treatment of chronic hepatitis C virus infection

By Herbst D Alan   Reddy K Rajender  

Expert Opinion on Investigational Drugs, Vol. 22, Iss. 10, 2013-10 ,pp. : 1337-1346

Informa Healthcare

Access to resources Recommend Favorite